. 2022 Feb 2;126(9):1355–1361. doi: 10.1038/s41416-022-01714-9

Table 6.

Projected additional breast cancer deaths incurred due to the 2020 cessation of screening, for combinations of assumptions with respect to missing data and the remaining backlog at the end of June 2021.

	Whole of backlog cleared	50% of backlog cleared
Source of additional breast cancer deaths
- Symptomatic detection of cancers that would have been screen-detected^a	148–275	242–452
- Delayed screen detection	222	164
- Progression of DCIS	97	71
Total^a	467–594	477–687

^aRange represents optimistic and pessimistic scenarios.